Literature DB >> 8849653

Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.

F Barchiesi1, R J Hollis, S A Messer, G Scalise, M G Rinaldi, M A Pfaller.   

Abstract

Electrophoretic karyotype (EK) was used to type 13 clinical isolates of Cryptococcus neoformans from eight AIDS patients. All of the isolates were also tested for their in vitro susceptibilities to fluconazole, itraconazole, D0870, flucytosine, and amphotericin B by a broth macrodilution technique performed according to the National Committee for Clinical Laboratory Standards recommendations. Although all strains were isolated from a limited geographic area, DNA typing showed a wide genetic variation in this group of patients, yielding seven different patterns. Two patients in whom C. neoformans was isolated in the same time period shared similar EK profiles, suggesting the possibility of cross-infection. In three patients, sequential isolates were evaluated: in two of them, EK analysis showed the persistence of the same genotype throughout the infection, whereas from the third, two isolates of C. neoformans with two different DNA profiles were obtained. Despite the small number of strains considered in this study, our susceptibility data indicate that C. neoformans isolates are very susceptible to the new triazoles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8849653     DOI: 10.1016/0732-8893(95)00169-7

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Electrophoretic karyotypes of C. neoformans serotype A recovered from Thai patients with AIDS.

Authors:  Puriya Ngamwongsatit; Samaniya Sukroongreung; Churairatana Nilakul; Virapong Prachayasittikul; Srisurang Tantimavanich
Journal:  Mycopathologia       Date:  2005-02       Impact factor: 2.574

3.  Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.

Authors:  W R Kirkpatrick; R K McAtee; S G Revankar; A W Fothergill; D I McCarthy; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.

Authors:  B M Calvo; A L Colombo; O Fischman; A Santiago; L Thompson; M Lazera; F Telles; K Fukushima; K Nishimura; R Tanaka; M Myiajy; M L Moretti-Branchini
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Phenotypic switching and genetic diversity of Cryptococcus neoformans.

Authors:  S Sukroongreung; S Lim; S Tantimavanich; B Eampokalap; D Carter; C Nilakul; S Kulkeratiyut; S Tansuphaswadikul
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

6.  Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.

Authors:  C J Jessup; M A Pfaller; S A Messer; J Zhang; M Tumberland; E K Mbidde; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas.

Authors:  A C N Delgado; H Taguchi; Y Mikami; M Myiajy; M C B Villares; M L Moretti
Journal:  Mycopathologia       Date:  2005-01       Impact factor: 2.574

8.  Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.

Authors:  T Yamazumi; M A Pfaller; S A Messer; A K Houston; L Boyken; R J Hollis; I Furuta; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994.

Authors:  M E Klepser; M A Pfaller
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

10.  First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an Ivorian HIV-positive patient.

Authors:  Fulgence K Kassi; Virginie Bellet; Adama Doumbia; Donika Krasteva; Pascal Drakulovski; Gisèle A Kouakou; François Gatchitch; Eric Delaporte; Jacques Reynes; Michèle Mallié; Hervé I E Menan; Sébastien Bertout
Journal:  JMM Case Rep       Date:  2016-08-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.